NICE nixes lapatinib and trastuzumab with aromatase inhibitors as first-line treatments for some breast cancer - http://bit.ly/yGIw6U
8:59 AM - 14 Feb 2012
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.